학술논문

Self-testing for cancer: a community survey.
Document Type
Article
Source
BMC Cancer. 2008, Vol. 8, Special section p1-7. 7p. 1 Diagram, 3 Charts.
Subject
*PATIENT self-monitoring
*DIAGNOSTIC reagents & test kits
*CANCER diagnosis
*PATIENT monitoring equipment
*HEALTH behavior
*MEDICAL care use
Language
ISSN
1471-2407
Abstract
Background: Cancer-related self-tests are currently available to buy in pharmacies or over the internet, including tests for faecal occult blood, PSA and haematuria. Self-tests have potential benefits (e.g. convenience) but there are also potential harms (e.g. delays in seeking treatment). The extent of cancer-related self-test use in the UK is not known. This study aimed to determine the prevalence of cancer-related self-test use. Methods: Adults (n = 5,545) in the West Midlands were sent a questionnaire that collected sociodemographic information and data regarding previous and potential future use of 18 different selftests. Prevalence rates were directly standardised to the England population. The postcode based Index of Multiple Deprivation 2004 was used as a proxy measure of deprivation. Results: 2,925 (54%) usable questionnaires were returned. 1.2% (95% CI 0.83% to 1.66%) of responders reported having used a cancer related self test kit and a further 36% reported that they would consider using one in the future. Logistic regression analyses suggest that increasing age, deprivation category and employment status were associated with cancer-related self-test kit use. Conclusion: We conclude that one in 100 of the adult population have used a cancer-related selftest kit and over a third would consider using one in the future. Self-test kit use could alter perceptions of risk, cause psychological morbidity and impact on the demand for healthcare. [ABSTRACT FROM AUTHOR]